These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 52143)

  • 1. [Mechanisms of inactivation of aminosides. Relationship to phenotype in Gram negative bacilli].
    Witchitz JL
    Nouv Presse Med; 1975 Sep; 4(30):2187-90. PubMed ID: 52143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 2. Mechanism of resistance (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):384-92. PubMed ID: 779354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
    Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aminoglycoside desoxystreptamine-containing antibiotics].
    Gol'dberg LE
    Antibiotiki; 1976 Nov; 21(11):1033-50. PubMed ID: 65938
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of the new aminoglycoside antibiotics: tobramycin, lividomycin, amikacin, sisomicin in the patient with normal renal function and in renal insufficiency. Dosage rules].
    Oksenhendler G; Leroy A; Humbert G; Fillastre JP; Winckler C
    Anesth Analg (Paris); 1977; 34(1):93-110. PubMed ID: 587022
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
    Witchitz JL; Golstein FW; Pangon B; Christol D; Acar JF
    Nouv Presse Med; 1979 Oct; 8(42):3417-20. PubMed ID: 537886
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profiles of resistance to aminosides of Pseudomonas aeruginosa].
    Lesage D; Delisle-Mizon F; Vergez P; Daguet G
    Pathol Biol (Paris); 1987 May; 35(5):552-7. PubMed ID: 3112707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A growing clinical problem: plasmid-determined resistance to aminocyclitol-aminoglycosides in enterobacteria.
    Gómez-Lus R; Rivera MJ; Vitoria MA
    Chemioterapia; 1984 Dec; 3(6):368-70. PubMed ID: 6099225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of resistance to various aminoglycoside antibiotics.
    Pisano A; Mattina R; Nicoletti G
    Antibiotica; 1977 Mar; 14(1):58-72. PubMed ID: 879719
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.
    Marengo PB; Chenoweth ME; Overturf GD; Wilkins J
    Antimicrob Agents Chemother; 1974 Dec; 6(6):821-4. PubMed ID: 4455126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activity of tobramycin on enterobacteria. Present aspects of resistance factors].
    Witchitz J
    Nouv Presse Med; 1974 Apr; 3(0):43-6. PubMed ID: 4837114
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measuring the excretion of aminoglycosides into the saliva].
    Kelentey BA; Kelentey BJ
    Fogorv Sz; 1991 Oct; 84(10):313-7. PubMed ID: 1765204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):713-7. PubMed ID: 121911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
    Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
    Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.